Zhao; Jiuyang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhao; Jiuyang.The latest application filed is for "di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity".

Company Profile

8.9.10

Zhao; Jiuyang - Guangdong CN
Zhao; Jiuyang - Shenzhen CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors Grant 11,453,672 - Wang , et al. September 27, 2	2022-09-27
Antiviral nucleoside reverse transcriptase inhibitor Grant 11,447,512 - Wang , et al. September 20, 2	2022-09-20
Antiviral nucleoside reverse transcriptase inhibitor Grant 11,389,463 - Wang , et al. July 19, 2	2022-07-19
Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity Grant 11,358,973 - Wang , et al. June 14, 2	2022-06-14
Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound Grant 11,345,703 - Wang , et al. May 31, 2	2022-05-31
(Hetero)arylamide compound for inhibiting protein kinase activity Grant 11,319,317 - Wang , et al. May 3, 2	2022-05-03
(Hetero)arylamide compound for inhibiting protein kinase activity Grant 11,091,462 - Wang , et al. August 17, 2	2021-08-17
Di(hetero)aryl Macrocyclic Compound For Inhibiting Protein Kinase Activity App 20210171542 - Wang; Yihan ; et al.	2021-06-10
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20210171517 - Wang; Yihan ; et al.	2021-06-10
Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof Grant 10,995,103 - Wang , et al. May 4, 2	2021-05-04
Substituted Pyrazolo[1,5-a]pyrimidine Compound And Pharmaceutical Composition And Use Thereof App 20210107906 - WANG; Yihan ; et al.	2021-04-15
Novel Antiviral Nucleoside Reverse Transcriptase Inhibitor App 20210093650 - Wang; Yihan ; et al.	2021-04-01
Substituted Pyrazolo[1,5-a]pyrimidine Macrocyclic Compound App 20210047330 - WANG; Yihan ; et al.	2021-02-18
(Hetero)arylamide compound for inhibiting protein kinase activity Grant 10,875,853 - Wang , et al. December 29, 2	2020-12-29
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20200377473 - WANG; Yihan ; et al.	2020-12-03
Antiviral Nucleoside Reverse Transcriptase Inhibitor App 20200369696 - Wang; Yihan ; et al.	2020-11-26
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20190382374 - WANG; Yihan ; et al.	2019-12-19
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20190375745 - Wang; Yihan ; et al.	2019-12-12
Substituted Boric Acid Compound, Pharmaceutical Composition Comprising Same, And Application Thereof App 20190263835 - Wang; Yihan ; et al.	2019-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.